Mesoblast Limited

Announcements / Press Releases

2013-December-20	Appendix 3B (in PDF)
2013-December-4	Mesoblast Reports Positive Type 2 Diabetes Trial Results (in PDF)
2013-November-25	New Japanese Regenerative Medicine Legislation (in PDF)
2013-November-22	Scrip Award to Mesoblast for 2013 Financing Deal of the Year (in PDF)
2013-November-19	MPCs Strengthen Cardiac Function in End-Stage Heart Failure (in PDF)
2013-November-15	Results of Meeting (in PDF)
2013-November-15	Chairman's Address to Shareholders (in PDF)
2013-November-14	Improved Survival in Children with GvHD After Cell Therapy (in PDF)
2013-November-11	MPCs Induce Functional Recovery in Ischemic Stroke Model (in PDF)
2013-October-31	FDA Clears Phase 3 Heart Failure Trial (in PDF)
2013-October-28	MSBs Registration Plans for GVHD Cell Product in Japan (in PDF)
2013-October-25	Appendix 4C - Quarterly (in PDF)
2013-October-24	Mesoblast, Intrexon and Ziopharm to Target Cancers (in PDF)
2013-October-15	Notice of Annual General Meeting/Proxy Form (in PDF)
2013-October-11	Mesoblast Acquires Osiris' Cultured Stem Cell Business (in PDF)
2013-September-19	Spinal Fusion Trial to be Presented at Premier Spine Forum (in PDF)
2013-September-16	Appendix 3B (in PDF)
2013-September-2	Share Trading Policy (in PDF)
2013-August-29	Strong Cash Position Enables Execution of Late-Stage Trials (in PDF)
2013-August-29	Preliminary Final Report for the Year Ended 30 June 2013 (in PDF)
2013-August-29	Appendix 4E - Preliminary Final Report Year Ending on 30 June 2013 (in PDF)
2013-August-1	Appendix 4C - Quarterly (in PDF)
2013-July-18	MSB Receives $4.3M Pipeline Funds from Australian Government (in PDF)
2013-June-26	MSB to Begin Phase 2 Trial of MPCs in Diabetic Nephropathy (in PDF)
2013-June-5	Key Mesenchymal Precursor Cell Patent Granted in Japan (in PDF)
2013-May-15	Circulation Research Publishes AMI Preclinical Trial Results (in PDF)
2013-April-30	Appendix 4C - Quarterly (in PDF)
2013-April-30	Appendix 3B (in PDF)
2013-April-22	Positive Interim Results in Phase 2 Trial for Disc Repair (in PDF)
2013-April-17	Director Appointment/Resignation (in PDF)
2013-April-12	CEO Awarded Inaugural Pontifical Award for Innovation (in PDF)
2013-March-14	Mesoblast Completes A$170M Private Placement (in PDF)
2013-March-14	Cleansing Notice Under Section 708A of the Corporations Act (in PDF)
2013-March-14	Appendix 3B (in PDF)
2013-March-6	Mesoblast Enters into Agreements to Raise A$170 Million (in PDF)
2013-February-13	FDA Agree on Use of MSBs Singapore Manufacturing Facility (in PDF)
2013-February-11	Half Year Report - 31 December 2012 (in PDF)
2013-February-11	2013 1H Results: Strategic Update (in PDF)
2013-February-7	Key MPC Patents Granted in United States and China (in PDF)
2013-January-31	Appendix 4C - Quarterly (in PDF)
2013-January-31	Appendix 3B (in PDF)
2013-January-30	FDA Clears Phase 2 Clinical Trial for Rheumatoid Arthritis (in PDF)
2013-January-11	Positive Results in Phase 2 Lumbar Spinal Fusion Trial (in PDF)
2017	2017 Announcements / Press Releases
2016	2016 Announcements / Press Releases
2015	2015 Announcements / Press Releases
2014	2014 Announcements / Press Releases
2012	2012 Announcements / Press Releases
2011	2011 Announcements / Press Releases
2010	2010 Announcements / Press Releases
2009	2009 Announcements / Press Releases
2008	2008 Announcements / Press Releases
2007	2007 Announcements / Press Releases